Global Obstetrics & Gynecology Issue #53 #31st May 2025
1. YOUniverse
🎥 UNRAVELING MALIGNANCY RISKS: A Comparative Analysis of Four Indices for Adnexal Mass Assessment – Delivered by Dr. Niranjan Chavan as the prestigious ICOG – Dr. USHA SARAIYA ORATION 2024 at the 31st Madurai Obstetric & Gynaecological Society Annual Conference in Madurai, Tamil Nadu, this oration presents a comprehensive comparative analysis of Risk of Malignancy Indices (RMI 1, 2, 3 & 4) in evaluating adnexal masses. It highlights key clinical insights on the sensitivity, specificity, and overall diagnostic accuracy of each index, offering practical guidance for differentiating between benign and malignant ovarian lesions.
2. ArticleAlley
Cervical Ectopic Pregnancy is a rare and high-risk condition requiring early diagnosis to avoid severe complications. This case of a 43-year-old IVF-conceived primigravida with painless vaginal bleeding at 6 weeks was accurately diagnosed using ultrasound and MRI. She was successfully managed conservatively with medical therapy and β-hCG monitoring, avoiding surgery and preserving fertility. The case underscores the importance of prompt, individualised, and fertility-preserving management in Cervical ectopic pregnancy.
3. PublicationPlanet
Complete Situs Inversus is a rare condition, inherited in an autosomal recessive pattern, caused by the inversion of cardiac tube rotation during embryonic development. It affects about 1 in 10,000 births. We'd like to report an interesting case where situs inversus was identified during the antenatal period and had an uneventful outcome. A 28-year-old woman, G2P1L1, with 32.3 weeks of pregnancy following a spontaneous conception, presented to the outpatient department of a tertiary care hospital for antenatal care registration with a recent diagnosis of situs inversus totalis. With regular follow-up, delivered a full-term baby by cesarean section at 39.1 weeks of gestation. Despite the rarity of this condition, it resulted in an uneventful pregnancy course.
4. SlideScope
Post-Exposure Prophylaxis (PEP) involves taking antiretroviral drugs within 72 hours of potential exposure to HIV to prevent infection. Factors like the amount of blood and virus levels can influence transmission risk from needlesticks or other exposures. Proper wound care and starting a 28-day course of antiretroviral drugs are recommended. Follow-up testing for the exposed person is also important to monitor for potential infection. The goals of PEP are to suppress viral replication and prevent the establishment of HIV infection after a possible exposure.
IF YOU ENJOYED THIS ARTICLE AND WANT MORE CONTENT LIKE THIS:
1. Subscribe to The Global Obstetrics & Gynecologic Newsletter to get notified when a new issue arises.
2. You can also connect with Dr. Niranjan Chavan on LinkTree.
Student at Maharashtra University of Health Sciences
3mo👏👏